The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch this webinar to learn about how this test is being utilized by urologists and radiation oncologists across the country to optimize cancer care.
Dr. Kenneth Nepple (University of Iowa) and Dr. Nicolas Zouain (West Florida Radiation Therapy) joins Dr. Calvin Chao (VP Medical Science, Artera) in reviewing the Past, Present, and Future of the ArteraAI Prostate Test.
- How the test was developed and validated
- 4 Real-world patient cases, including how the test impacted treatment decisions
- Latest ASCO data presentation on adjunctive abiraterone insights
Fill out the form below to view the recording…
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch this webinar to learn about how this test is being utilized by urologists and radiation oncologists across the country to optimize cancer care.
Dr. Kenneth Nepple (University of Iowa) and Dr. Nicolas Zouain (West Florida Radiation Therapy) joins Dr. Calvin Chao (VP Medical Science, Artera) in reviewing the Past, Present, and Future of the ArteraAI Prostate Test.
Watch below for a lively discussion on:
- How the test was developed and validated
- 4 Real-world patient cases, including how the test impacted treatment decisions
- Latest ASCO data presentation on adjunctive abiraterone insights
